Prenetics Global Limited (PRENW)
USD 0.01
(1.02%)
USD 0.01
(1.02%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 254.17 Million USD | -17.47% |
| 2022 | 307.97 Million USD | 107.38% |
| 2021 | 148.5 Million USD | 88.26% |
| 2020 | 78.88 Million USD | 165.72% |
| 2019 | 29.68 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 233.3 Million USD | -4.22% |
| 2024 Q1 | 243.58 Million USD | -4.16% |
| 2023 Q3 | 276.41 Million USD | -1.58% |
| 2023 FY | 254.17 Million USD | -17.47% |
| 2023 Q4 | 254.17 Million USD | -8.05% |
| 2023 Q2 | 280.83 Million USD | -3.51% |
| 2023 Q1 | 291.04 Million USD | -5.5% |
| 2022 Q2 | 278.24 Million USD | 64.08% |
| 2022 Q1 | 169.57 Million USD | 14.19% |
| 2022 Q4 | 307.97 Million USD | 14.23% |
| 2022 FY | 307.97 Million USD | 107.38% |
| 2022 Q3 | 269.6 Million USD | -3.11% |
| 2021 FY | 148.5 Million USD | 88.26% |
| 2021 Q1 | 100.88 Million USD | 27.9% |
| 2021 Q3 | 340.41 Million USD | -0.27% |
| 2021 Q4 | 148.5 Million USD | -56.38% |
| 2021 Q2 | 341.34 Million USD | 238.34% |
| 2020 Q4 | 78.88 Million USD | 0.0% |
| 2020 FY | 78.88 Million USD | 165.72% |
| 2019 FY | 29.68 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aspira Women's Health Inc. | 6.26 Million USD | -3958.935% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -2991.515% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -1744.641% |
| Standard BioTools Inc. | 323.06 Million USD | 21.326% |
| Inotiv, Inc. | 856.53 Million USD | 70.326% |
| Neuronetics, Inc. | 115.83 Million USD | -119.432% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -192.237% |
| Castle Biosciences, Inc. | 477.81 Million USD | 46.805% |
| Psychemedics Corporation | 13.27 Million USD | -1815.377% |
| RadNet, Inc. | 2.88 Billion USD | 91.195% |
| Exact Sciences Corporation | 6.47 Billion USD | 96.072% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 92.203% |
| iSpecimen Inc. | 15.81 Million USD | -1506.728% |
| OpGen, Inc. | 1.88 Million USD | -13403.375% |
| Exagen Inc. | 56.94 Million USD | -346.352% |
| Bionano Genomics, Inc. | 214.4 Million USD | -18.547% |
| CareDx, Inc | 484.61 Million USD | 47.552% |
| Check-Cap Ltd. | 25.01 Million USD | -915.991% |
| Twist Bioscience Corporation | 776.4 Million USD | 67.263% |
| Guardant Health, Inc. | 1.78 Billion USD | 85.772% |
| Biodesix, Inc. | 99.09 Million USD | -156.489% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -2129.606% |
| Precipio, Inc. | 18.1 Million USD | -1304.179% |
| Natera, Inc. | 1.45 Billion USD | 82.557% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | 80.035% |
| Sera Prognostics, Inc. | 95.44 Million USD | -166.312% |
| 23andMe Holding Co. | 395.16 Million USD | 35.68% |
| OPKO Health, Inc. | 2.01 Billion USD | 87.365% |
| Personalis, Inc. | 225.09 Million USD | -12.915% |
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -28.756% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -1761.84% |
| T2 Biosystems, Inc. | 34.79 Million USD | -630.438% |
| Neogen Corporation | 4.58 Billion USD | 94.455% |
| Myriad Genetics, Inc. | 1.19 Billion USD | 78.796% |
| ICON Public Limited Company | 16.98 Billion USD | 98.504% |
| NeoGenomics, Inc. | 1.68 Billion USD | 84.882% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -192.237% |
| MDxHealth SA | 129.13 Million USD | -96.83% |
| Prenetics Global Limited | 254.17 Million USD | 0.0% |
| Illumina, Inc. | 10.11 Billion USD | 97.486% |
| DarioHealth Corp. | 96.38 Million USD | -163.692% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -3663.178% |
| Medpace Holdings, Inc. | 1.65 Billion USD | 84.659% |
| Mainz Biomed B.V. | 15.4 Million USD | -1549.491% |
| Trinity Biotech plc | 59.43 Million USD | -327.645% |
| Sotera Health Company | 3.13 Billion USD | 91.881% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -2991.515% |